NCT03023293

Brief Summary

This study aims to investigate the associations of maternal nutritional status during pregnancy and postpartum periods with postpartum abnormal glucose metabolism in Guangzhou pregnant women. Additionally, it seeks to explore the relationships between maternal nutritional status (pre- and postnatal) and offspring health outcomes, including physical growth, neurodevelopment, and common childhood diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,122

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 18, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

March 10, 2017

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

7.8 years

First QC Date

January 13, 2017

Last Update Submit

April 11, 2026

Conditions

Keywords

n-3 polyunsaturated fatty acidsDietary patternsNutritional statusIrisin

Outcome Measures

Primary Outcomes (4)

  • Maternal glucose metabolism

    Maternal glycemic indicators measured during pregnancy (24-28 weeks of gestation) using a 75g oral glucose tolerance test (OGTT), including fasting plasma glucose (FPG), 1-hour post-load glucose, 2-hour post-load glucose, and hemoglobin A1c (HbA1c). Fasting insulin levels are measured by enzyme-linked immunosorbent assay (ELISA), and insulin resistance is estimated using the homeostasis model assessment of insulin resistance (HOMA-IR).

    Gestation (24-28 weeks) and, for fasting glucose, also at 42 days postpartum.

  • Offspring physical growth and development

    Including weight, length/height, head circumference, body mass index (BMI), and growth trajectories from birth to 5 years of age.

    Birth, 6 months, 2 years, 3-4 years, and 5 years of age.

  • Offspring neuropsychological development

    Including executive function, emotional and behavioral problems (e.g., Strengths and Difficulties Questionnaire), developmental milestones (e.g., Ages and Stages Questionnaire), and other neuropsychological assessments at 2, 3-4, and 5 years of age.

    2 years, 3-4 years, and 5 years of age.

  • Offspring allergic diseases

    Including physician-diagnosed or parent-reported eczema, food allergy, atopic dermatitis, allergic rhinitis, and asthma during the first 5 years of life.

    6 months, 2 years, and 3-4 years.

Secondary Outcomes (4)

  • Maternal postpartum weight

    42 days postpartum.

  • Maternal postpartum blood pressure

    42 days postpartum.

  • Offspring vision problems

    3-4 years and 5 years of age.

  • Offspring dental caries

    3-4 years and 5 years of age.

Study Arms (1)

No treatment

This cohort study have any no treatment.

Other: No intervention

Interventions

This cohort study have any no intervention.

No treatment

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women with or without gestational diabetes mellitus (GDM) and their offspring.

You may qualify if:

  • Age between 20 and 45 years (inclusive).
  • Singleton pregnancy.
  • Free from the following pre-pregnancy or pregnancy-related conditions:
  • pregestational diabetes mellitus, cardiovascular disease, thyroid disease, hematological disease, polycystic ovary syndrome, infection during pregnancy, or mental disorder.
  • \- Note: Women who meet all of the above criteria are eligible for the study, regardless of whether they have gestational diabetes mellitus (GDM) or not.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen University

Guangzhou, Guangdong, 510000, China

Location

Related Publications (7)

  • Villegas R, Xiang YB, Elasy T, Li HL, Yang G, Cai H, Ye F, Gao YT, Shyr Y, Zheng W, Shu XO. Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am J Clin Nutr. 2011 Aug;94(2):543-51. doi: 10.3945/ajcn.111.013193. Epub 2011 Jun 15.

    PMID: 21677058BACKGROUND
  • Nanri A, Mizoue T, Noda M, Takahashi Y, Matsushita Y, Poudel-Tandukar K, Kato M, Oba S, Inoue M, Tsugane S; Japan Public Health Center-based Prospective Study Group. Fish intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr. 2011 Sep;94(3):884-91. doi: 10.3945/ajcn.111.012252. Epub 2011 Jul 20.

    PMID: 21775559BACKGROUND
  • Brostow DP, Odegaard AO, Koh WP, Duval S, Gross MD, Yuan JM, Pereira MA. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2011 Aug;94(2):520-6. doi: 10.3945/ajcn.110.009357. Epub 2011 May 18.

    PMID: 21593505BACKGROUND
  • Zhao L, Li J, Li ZL, Yang J, Li ML, Wang GL. Circulating irisin is lower in gestational diabetes mellitus. Endocr J. 2015;62(10):921-6. doi: 10.1507/endocrj.EJ15-0230. Epub 2015 Jul 29.

    PMID: 26228794BACKGROUND
  • Kuzmicki M, Telejko B, Lipinska D, Pliszka J, Szamatowicz M, Wilk J, Zbucka-Kretowska M, Laudanski P, Kretowski A, Gorska M, Szamatowicz J. Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol. 2014 Sep;30(9):636-9. doi: 10.3109/09513590.2014.920006. Epub 2014 May 22.

    PMID: 24850254BACKGROUND
  • Vaughan RA, Garcia-Smith R, Bisoffi M, Conn CA, Trujillo KA. Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells. Lipids Health Dis. 2012 Oct 30;11:142. doi: 10.1186/1476-511X-11-142.

    PMID: 23107305BACKGROUND
  • Tang N, He Y, Karatela S, Zhong J, Zeng X, Lu Q, Zhao F, Cai L. Association between erythrocyte polyunsaturated fatty acids and gestational diabetes mellitus in Chinese pregnant women. Eur J Nutr. 2025 Feb 11;64(2):87. doi: 10.1007/s00394-025-03603-2.

Biospecimen

Retention: SAMPLES WITH DNA

Fasting venous blood samples were collected from pregnant women at 20-28 weeks of gestation and at 42 days postpartum. The biospecimens were used to measure erythrocyte membrane fatty acids, plasma irisin, glucose, insulin, and lipid profiles. Remaining samples are stored at -80°C and may be used for future metabolomics and exposomics analyses.

MeSH Terms

Conditions

Diabetes, GestationalNeurodevelopmental DisordersProblem Behavior

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesMental DisordersBehavioral SymptomsBehaviorChild Behavior

Study Officials

  • Li Cai

    Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 13, 2017

First Posted

January 18, 2017

Study Start

March 10, 2017

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

April 15, 2026

Record last verified: 2026-04

Locations